Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV

被引:1
|
作者
Ng'uni, Tiza L. [1 ]
Musale, Vernon [2 ,3 ]
Nkosi, Thandeka [1 ]
Mandolo, Jonathan [4 ]
Mvula, Memory [4 ]
Michelo, Clive [2 ,3 ]
Karim, Farina [1 ]
Moosa, Mohomed Yunus S. [5 ]
Khan, Khadija [1 ]
Jambo, Kondwani Charles [4 ,6 ]
Hanekom, Willem [1 ,7 ]
Sigal, Alex [1 ]
Kilembe, William [2 ,3 ]
Ndhlovu, Zaza M. [1 ,5 ,8 ,9 ]
机构
[1] Africa Hlth Res Inst AHRI, Nelson R Mandela Sch Med, Durban, South Africa
[2] Emory Univ Georgia, Ctr Excellence Influenza Res & Surveillance CEIRS, Lusaka, Zambia
[3] Ctr Family Hlth Res Zambia CFHRZ, Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia
[4] Infect & Immun Res Grp, Malawi Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi
[5] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Human Immunodeficiency Virus HIV Pathogenesis Prog, Durban, South Africa
[6] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, England
[7] UCL, Div Infect & Immun, London, England
[8] Ragon Inst Massachusetts Gen Hosp MGH, Massachusetts Inst Technol MIT, Cambridge, MA 02139 USA
[9] Harvard Univ, Cambridge, MA 02138 USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
英国惠康基金; 美国国家卫生研究院;
关键词
HIV; SARS-CoV-2; HCoV-NL63; COVID-19; T-cell response; antibody response; ANTIBODIES;
D O I
10.3389/fimmu.2023.1291048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Understanding how HIV affects SARS-CoV-2 immunity is crucial for managing COVID-19 in sub-Saharan populations due to frequent coinfections. Our previous research showed that unsuppressed HIV is associated with weaker immune responses to SARS-CoV-2, but the underlying mechanisms are unclear. We investigated how pre-existing T cell immunity against an endemic human coronavirus HCoV-NL63 impacts SARS-CoV-2 T cell responses in people living with HIV (PLWH) compared to uninfected individuals, and how HIV-related T cell dysfunction influences responses to SARS-CoV-2 variants.Methods We used flow cytometry to measure T cell responses following PBMC stimulation with peptide pools representing beta, delta, wild-type, and HCoV-NL63 spike proteins. Luminex bead assay was used to measure circulating plasma chemokine and cytokine levels. ELISA and MSD V-PLEX COVID-19 Serology and ACE2 Neutralization assays were used to measure humoral responses.Results Regardless of HIV status, we found a strong positive correlation between responses to HCoV-NL63 and SARS-CoV-2. However, PLWH exhibited weaker CD4+ T cell responses to both HCoV-NL63 and SARS-CoV-2 than HIV-uninfected individuals. PLWH also had higher proportions of functionally exhausted (PD-1high) CD4+ T cells producing fewer proinflammatory cytokines (IFN gamma and TNF alpha) and had elevated plasma IL-2 and IL-12(p70) levels compared to HIV-uninfected individuals. HIV status didn't significantly affect IgG antibody levels against SARS-CoV-2 antigens or ACE2 binding inhibition activity.Conclusion Our results indicate that the decrease in SARS-CoV-2 specific T cell responses in PLWH may be attributable to reduced frequencies of pre-existing cross-reactive responses. However, HIV infection minimally affected the quality and magnitude of humoral responses, and this could explain why the risk of severe COVID-19 in PLWH is highly heterogeneous.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Alrubayyi, Aljawharah
    Gea-Mallorqui, Ester
    Touizer, Emma
    Hameiri-Bowen, Dan
    Kopycinski, Jakub
    Charlton, Bethany
    Fisher-Pearson, Natasha
    Muir, Luke
    Rosa, Annachiara
    Roustan, Chloe
    Earl, Christopher
    Cherepanov, Peter
    Pellegrino, Pierre
    Waters, Laura
    Burns, Fiona
    Kinloch, Sabine
    Dong, Tao
    Dorrell, Lucy
    Rowland-Jones, Sarah
    McCoy, Laura E.
    Peppa, Dimitra
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi
    Ester Gea-Mallorquí
    Emma Touizer
    Dan Hameiri-Bowen
    Jakub Kopycinski
    Bethany Charlton
    Natasha Fisher-Pearson
    Luke Muir
    Annachiara Rosa
    Chloe Roustan
    Christopher Earl
    Peter Cherepanov
    Pierre Pellegrino
    Laura Waters
    Fiona Burns
    Sabine Kinloch
    Tao Dong
    Lucy Dorrell
    Sarah Rowland-Jones
    Laura E. McCoy
    Dimitra Peppa
    Nature Communications, 12
  • [3] Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
    Schulien, Isabel
    Kemming, Janine
    Oberhardt, Valerie
    Wild, Katharina
    Seidel, Lea M.
    Killmer, Saskia
    Sagar
    Daul, Franziska
    Salvat Lago, Marilyn
    Decker, Annegrit
    Luxenburger, Hendrik
    Binder, Benedikt
    Bettinger, Dominik
    Sogukpinar, Oezlem
    Rieg, Siegbert
    Panning, Marcus
    Huzly, Daniela
    Schwemmle, Martin
    Kochs, Georg
    Waller, Cornelius F.
    Nieters, Alexandra
    Duerschmied, Daniel
    Emmerich, Florian
    Mei, Henrik E.
    Schulz, Axel Ronald
    Llewellyn-Lacey, Sian
    Price, David A.
    Boettler, Tobias
    Bengsch, Bertram
    Thimme, Robert
    Hofmann, Maike
    Neumann-Haefelin, Christoph
    NATURE MEDICINE, 2021, 27 (01) : 78 - +
  • [4] FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses
    Tiezzi, Camilla
    Rossi, Marzia
    Vecchi, Andrea
    Doselli, Sara
    Penna, Amalia
    Fisicaro, Paola
    Montali, Ilaria
    Berti, Camilla Ceccatelli
    Reverberi, Valentina
    Montali, Anna
    Missale, Gabriele
    Ferrari, Carlo
    Boni, Carolina
    STAR PROTOCOLS, 2023, 4 (04):
  • [5] Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
    Isabel Schulien
    Janine Kemming
    Valerie Oberhardt
    Katharina Wild
    Lea M. Seidel
    Saskia Killmer
    Franziska Sagar
    Marilyn Daul
    Annegrit Salvat Lago
    Hendrik Decker
    Benedikt Luxenburger
    Dominik Binder
    Oezlem Bettinger
    Siegbert Sogukpinar
    Marcus Rieg
    Daniela Panning
    Martin Huzly
    Georg Schwemmle
    Cornelius F. Kochs
    Alexandra Waller
    Daniel Nieters
    Florian Duerschmied
    Henrik E. Emmerich
    Axel Ronald Mei
    Sian Schulz
    David A. Llewellyn-Lacey
    Tobias Price
    Bertram Boettler
    Robert Bengsch
    Maike Thimme
    Christoph Hofmann
    Nature Medicine, 2021, 27 : 78 - 85
  • [6] SARS-CoV-2 mRNA Vaccines Induce Broad CD4+T cell Responses that Recognize SARS-CoV-2 Variants and HCoV-NL63
    Short, Sarah L.
    Wall, Luke A.
    PEDIATRICS, 2021, 148 : S73 - S74
  • [7] SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
    Woldemeskel, Bezawit A.
    Garliss, Caroline C.
    Blankson, Joel N.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (10):
  • [8] SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
    Shankar, Sushma
    Beckett, Joseph
    Tipton, Tom
    Ogbe, Ane
    Kasanyinga, Mwila
    Dold, Christina
    Lumley, Sheila
    Dengu, Fungai
    Rompianesi, Gianluca
    Elgilani, Faysal
    Longet, Stephanie
    Deeks, Alexandra
    Payne, Rebecca P.
    Duncan, Christopher J. A.
    Richter, Alex
    de Silva, Thushan I.
    Turtle, Lance
    Bull, Katherine
    Barnardo, Martin
    Friend, Peter J.
    Dunachie, Susanna J.
    Hester, Joanna
    Issa, Fadi
    Barnes, Eleanor
    Carroll, Miles W.
    Klenerman, Paul
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (05): : 883 - 887
  • [9] SARS-CoV-2-Specific T Cell Responses in Multisystem Inflammatory Syndrome in Children
    Lam, Ki Pui
    Chinas, Marcos H.
    Jule, Amelie M.
    Taylor, Maria
    Son, Mary Beth F.
    Chou, Janet
    Newburger, Jane W.
    Randolph, Adrienne G.
    Gutierrez-Arcelus, Maria
    Henderson, Lauren
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1147 - 1149
  • [10] Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
    Wang, Xiuwen
    Yang, Xiaodong
    Zhang, Xin
    Yan, Hongxia
    Jin, Junyan
    Ma, Zhenglai
    Duan, Junyi
    Zhang, Guanghui
    Huang, Tao
    Li, Yongzheng
    Wu, Hao
    Zhang, Tong
    Zhu, Aiwei
    Jin, Cong
    Song, Xiangrong
    Su, Bin
    FRONTIERS IN IMMUNOLOGY, 2025, 16